Press releases
- Interim report Q1, 2024: Strong growth in APAC and solid margins
- Correction: Notice to attend the Annual General Meeting of Vitrolife AB (publ)
- Conference call interim report
- Vitrolife Group Annual and Sustainability Report 2023
- Notice to attend the Annual General Meeting of Vitrolife AB (publ)
- Vitrolife AB (publ): Fourth quarter and full year report, 2023; continued growth with margin expansions
- Vitrolife AB (publ): Conference call full year report 2023
- Vitrolife Group makes an impairment charge of SEK 4.3 billion relating to Igenomix and provides preliminary financials for the fourth quarter 2023
More ▼
Key statistics
As of last trade, Vitrolife AB (VTFN:FRA) traded at 15.07, 41.37% above the 52 week low of 10.66 set on Sep 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.07 |
---|---|
High | 15.07 |
Low | 15.07 |
Bid | 14.38 |
Offer | 14.67 |
Previous close | 15.29 |
Average volume | 8.89 |
---|---|
Shares outstanding | 135.45m |
Free float | 75.08m |
P/E (TTM) | -- |
Market cap | 24.69bn SEK |
EPS (TTM) | -28.44 SEK |
Annual div (ADY) | 0.0857 EUR |
---|---|
Annual div yield (ADY) | 0.56% |
Div ex-date | Apr 28 2023 |
Div pay-date | May 05 2023 |
Next div ex-date | Apr 26 2024 |
Next div pay-date | May 03 2024 |
Data delayed at least 15 minutes, as of Apr 18 2024 08:32 BST.
More ▼